Chemoradiotherapy versus gemcitabine-based chemotherapy in patients with unresectable, locally advanced pancreatic cancer.

被引：3
|
作者：
Nio, K. [1 ]
Ueno, H. [1 ]
Okusaka, T. [1 ]
Morizane, C. [1 ]
Hagihara, A. [1 ]
Kondo, S. [1 ]
Mayahara, H. [1 ]
Ito, Y. [1 ]
机构：
[1] Natl Canc Ctr, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e14504
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14504
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Gemcitabine-based Concurrent Chemoradiotherapy Versus Chemotherapy Alone in Patients with Locally Advanced Pancreatic Cancer
    Wang, Bu-Hai
    Cao, Wen-Miao
    Yu, Jie
    Wang, Xiao-Lei
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (05) : 2129 - 2132
  • [2] Gemcitabine-based chemotherapy in advanced-metastatic and/or unresectable pancreatic cancer.
    Samelis, GF
    Areovimata, A
    Matsiakou, F
    Zografos, G
    Papakostas, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 376S - 376S
  • [3] Gemcitabine chemotherapy versus 5-fluorouracil-based concurrent chemoradiotherapy in locally advanced unresectable pancreatic cancer
    Park, Joo Kyung
    Ryu, Ji Kon
    Lee, Jun Kyu
    Yoon, Won Jae
    Lee, Sang Hyub
    Kim, Yong-Tae
    Yoon, Yong Bum
    PANCREAS, 2006, 33 (04) : 397 - 402
  • [4] Impact of Gemcitabine-Based Neoadjuvant Chemoradiotherapy as Preoperative Treatment for Locally Advanced Unresectable Pancreatic Adenocarcinoma
    Kishiwada, M.
    Kato, H.
    Nobuoka, Y.
    Azuni, Y.
    Hamada, T.
    Mizuno, S.
    Usui, M.
    Sakurai, H.
    Tabata, M.
    Isaji, S.
    PANCREAS, 2009, 38 (08) : 1017 - 1017
  • [5] Phase II study of induction chemotherapy with gemcitabine plus 5-fluorouracil followed by gemcitabine-based concurrent chemoradiotherapy for unresectable locally advanced pancreatic cancer
    Kurt, Ender
    Kurt, Meral
    Kanat, Ozkan
    Cetintas, Sibel Kahraman
    Aygun, Sevilcan
    Palazoglu, Julay
    Ozkan, Lutfi
    Evrensel, Turkkan
    Kaya, Ekrem
    Manavoglu, Osman
    TUMORI, 2006, 92 (06) : 481 - 486
  • [6] Helical tomotherapy and concurrent gemcitabine-based chemotherapy for locally advanced pancreatic cancer
    Seong, Jinsil
    Chang, Jisuk
    Song, Siyoung
    Keum, Woong
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [7] Treatment of metastatic and/or unresectable pancreatic cancer with gemcitabine-based chemotherapy
    Samelis, GF
    Zografos, G
    Areovimata, A
    Kitsou, V
    Papakostas, P
    ANNALS OF ONCOLOGY, 2005, 16 : 324 - 324
  • [8] Gemcitabine-Based Chemoradiotherapy Followed by Surgery for Borderline Resectable and Locally Unresectable Pancreatic Ductal Adenocarcinoma
    Kobayashi, Motoyuki
    Mizuno, Shugo
    Murata, Yasuhiro
    Kishiwada, Masashi
    Usui, Masanobu
    Sakurai, Hiroyuki
    Tabata, Masami
    Ii, Noriko
    Yamakado, Koichiro
    Inoue, Hiroyuki
    Shiraishi, Taizo
    Yamada, Tomomi
    Isaji, Shuji
    PANCREAS, 2014, 43 (03) : 350 - 360
  • [9] Chemoradiotherapy versus chemotherapy alone for unresectable locally advanced pancreatic cancer: a retrospective cohort study
    Maruki, Y.
    Ueno, H.
    Sasaki, M.
    Sakamoto, Y.
    Kondo, S.
    Morizane, C.
    Ito, Y.
    Okusaka, T.
    ANNALS OF ONCOLOGY, 2016, 27 : 35 - 35
  • [10] EFFICACY OF GEMCITABINE/NAB-PACLITAXEL INDUCTION CHEMOTHERAPY FOLLOWED BY CHEMORADIOTHERAPY FOR UNRESECTABLE LOCALLY ADVANCED PANCREATIC CANCER
    Takada, Ryoji
    Ikezawa, Kenji
    Kiyota, Ryosuke
    Imai, Toshihiro
    Yutaro, Abe
    Fukutake, Nobuyasu
    Takatoshi, Nawa
    Katayama, Kazuhiro
    Ohkawa, Kazuyoshi
    GASTROENTEROLOGY, 2020, 158 (06) : S865 - S866
12345